Rock Springs Capital Management’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-241,500
Closed -$33.8M 139
2018
Q4
$33.8M Buy
241,500
+38,519
+19% +$5.85M 1.6% 13
2018
Q3
$34.7M Sell
202,981
-86,919
-30% -$14.6M 1.26% 18
2018
Q2
$50.3M Sell
289,900
-26,600
-8% -$4M 1.94% 11
2018
Q1
$36.5M Buy
316,500
+6,500
+2% +$691K 1.56% 16
2017
Q4
$26.1M Buy
310,000
+24,500
+9% +$2.04M 1.18% 24
2017
Q3
$26.3M Sell
285,500
-2,500
-0.9% -$194K 1.21% 22
2017
Q2
$23.1M Buy
288,000
+107,000
+59% +$5.93M 1.17% 24
2017
Q1
$7.62M Buy
+181,000
New +$7.45M 0.44% 69

Other funds holding LOXO

Rock Springs Capital Management's LOXO Position: Q1 2019 in Review

Rock Springs Capital Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 241,500 shares — an estimated $33.8M sold.

Rock Springs Capital Management first reported a position in LOXO in Q1 2017 and held it in 8 quarters. The position peaked at $50.3M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Rock Springs Capital Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Rock Springs Capital Management sold 241,500 Loxo Oncology, Inc shares in Q1 2019, an estimated $33.8M.
  • Rock Springs Capital Management first reported a position in Loxo Oncology, Inc in Q1 2017 and held it in 8 quarters.
  • Rock Springs Capital Management's Loxo Oncology, Inc position peaked at $50.3M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Rock Springs Capital Management's 13F filing for Q1 2019, filed 15 May 2019.